Medpace Holdings (MEDP) Liabilities and Shareholders Equity (2015 - 2026)

Medpace Holdings (MEDP) has reported Liabilities and Shareholders Equity for 12 consecutive years, with $2.1 billion the latest figure, recorded in Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $2.1 billion, up 12.24% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.4 billion (down 7.16% YoY), and the FY2025 annual result was $2.0 billion, down 5.97% from the prior year.
• Liabilities and Shareholders Equity was $2.1 billion for Q1 2026 at Medpace Holdings, up from $2.0 billion in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $2.1 billion in Q1 2026 and troughed at $1.3 billion in Q2 2022.
• Average Liabilities and Shareholders Equity over 5 years is $1.7 billion, with a median of $1.7 billion recorded in 2023.
• Year-over-year, Liabilities and Shareholders Equity decreased 18.52% in 2022 and soared 40.18% in 2024.
• Over 5 years, Liabilities and Shareholders Equity stood at $1.4 billion in 2022, then grew by 22.5% to $1.7 billion in 2023, then grew by 26.8% to $2.1 billion in 2024, then decreased by 5.97% to $2.0 billion in 2025, then gained by 7.8% to $2.1 billion in 2026.
• Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $2.1 billion in Q1 2026, $2.0 billion in Q4 2025, and $1.8 billion in Q3 2025.